Chlamydia, gonorrhea and infectious syphilis in Canada: 2020 (infographic)

Download in PDF format
(1 MB, 1 page)

Organization: Public Health Agency of Canada
Type: Infographic
Date published: 2023-02-13

ISBN: 978-0-660-47203-4
Cat.: HP40-284/2020E-PDF
Pub.: 220710

The Public Health Agency of Canada collects information on reported cases of sexually transmitted infections (STI) such as chlamydia, gonorrhea and infectious syphilisFootnote 1 through the Canadian Notifiable Diseases Surveillance System (CNDSS).

Introduction

Reported rates of chlamydia, gonorrhea and infectious syphilis from 2011 to 2020

Reported rates of chlamydia, gonorrhea and infectious syphilis in Canada, 2011 to 2020

Figure 1: Reported rates of chlamydia overall and by sex in Canada, 2011 to 2020
Figure 1. Text version below.
Figure 1 - Text description

Text Description: Chlamydia

Figure 2: Reported rates of gonorrhea overall and by sex in Canada, 2011 to 2020
Figure 2. Text version below.
Figure 2 - Text description

Text Description: Gonorrhea

Figure 3: Reported rate of infectious syphilis overall and by sex in Canada, 2011 to 2020
Figure 3. Text version below.
Figure 3 - Text description

Text Description: Infectious syphilis

Number of reported cases of chlamydia, gonorrhea and infectious syphilis in 2020

In 2020, there were:

Reported rates of chlamydia, gonorrhea and infectious syphilis by province or territory in 2020

Proportion of reported cases of chlamydia, gonorrhea and infectious syphilis in 2020 by sex

Proportion of reported cases of chlamydia, gonorrhea and infectious syphilis in 2020 by age group

Appendix A: Data tables corresponding to STI figures

Table 1. Reported rates of chlamydia, gonorrhea and infectious syphilis per 100,000 population overall and by sex in Canada, 2011 to 2020
Year Chlamydia Gonorrhea Infectious syphilis
Male Female Total Male Female Total Male Female Total
2011 204.5 385.6 296.2 40.3 29.7 35.0 9.7 0.7 5.1
2012 216.2 390.4 304.3 42.8 32.6 37.7 11.3 0.6 5.9
2013 222.2 378.5 301.3 48.4 32.9 40.7 11.9 0.8 6.3
2014 232.1 384.8 309.4 59.1 33.1 46.0 12.7 0.9 6.8
2015 250.6 401.2 327.0 70.5 40.9 55.6 17.0 1.0 9.0
2016 263.1 408.8 337.0 84.7 47.1 65.9 19.9 1.7 10.8
2017 277.8 414.1 347.0 103.7 55.8 79.7 20.3 2.4 11.3
2018 296.8 424.1 361.6 124.4 63.7 94.1 27.2 6.9 17.1
2019 313.0 430.7 372.9 124.9 64.6 94.8 36.0 14.0 25.0
2020 229.1 326.7 278.9 102.4 59.5 81.1 34.3 14.9 24.6
The 'total' rate includes all males, females and those who did not disclose their sex (unknown sex).
Table 2. Reported rates of chlamydia, gonorrhea and infectious syphilis per 100,000 population overall and by sex, and province or territory in Canada, 2020
PT Chlamydia Gonorrhea Infectious syphilis
Male Female Total Male Female Total Male Female Total
BC 217.3 281.8 250.6 112.6 47.0 80.0 26.3 3.1 14.6
AB 260.8 378.5 319.5 126.0 95.3 110.8 63.8 49.8 56.9
SK 274.3 510.1 391.8 168.9 206.3 187.6 75.7 80.9 78.3
MB 360.7 618.7 490.4 216.0 274.2 245.2 119.5 116.5 118.0
ON 217.6 283.1 251.6 86.8 36.7 61.8 28.7 2.9 15.7
QC 216.4 321.1 269.6 97.5 33.6 65.8 21.9 3.0 12.5
NB 153.4 268.9 211.7 8.8 4.6 6.6 2.6 NA 1.8
NS 160.4 277.7 220.5 10.8 7.2 9.0 4.8 NA 2.8
PEI 148.0 261.8 206.3 11.4 6.1 8.7 NA NA NA
NL 108.4 193.4 151.4 2.7 0.8 1.7 7.7 NA 4.6
YT 501.4 759.3 628.3 51.5 38.7 45.2 NA NA NA
NT 1218.5 1958.7 1578.4 772.3 775.3 773.8 90.1 54.4 72.7
NU 2776.0 4892.8 3816.1 1969.9 2902.0 2433.3 95.7 163.3 128.7
Canada 229.1 326.7 278.9 102.4 59.5 81.1 34.3 14.9 24.6
NA: Data suppressed as there were less than 5 cases reported
The 'total' rate includes all males, females and those who did not disclose their sex (unknown sex).
Table 3. Proportions of all reported chlamydia, gonorrhea and infectious syphilis cases by sex and age group in Canada, 2020.
Age group (years) Chlamydia Gonorrhea Infectious syphilis
Male Female Total Male Female Total Male Female Total
15-24 41% 61% 53% 21% 41% 29% 12% 33% 19%
25-29 23% 19% 20% 22% 21% 22% 18% 23% 19%
30-39 23% 14% 18% 33% 25% 30% 33% 31% 33%
40+ 12% 5% 8% 24% 11% 19% 36% 13% 29%
The 'total' case count includes all males, females and those who did not disclose their sex (unknown sex).
Table 4. Number and proportion of reported cases of chlamydia, gonorrhea, and infectious syphilis by sex in Canada, 2020
Male cases (n) Proportion of male cases Female cases (n) Proportion of female cases Total cases (n)
Chlamydia 43,233 41% 62,494 59% 105,982
Gonorrhea 19,331 63% 11,388 37% 30,833
Infectious syphilis 6,475 69% 2,856 31% 9,358
The 'total' case count includes all males, females and those who did not disclose their sex (unknown sex).

Appendix B: List of supplementary tables and figures

Due to the impact of the COVID-19 pandemic on reported chlamydia, gonorrhea and infectious syphilis cases and rates, a 2020 STI in Canada surveillance report was not prepared by the Public Health Agency of Canada. However, the supplementary tables described below are available upon request via sti-hep-its@phac-aspc.gc.ca.   

Tables

Figures

Notes

For more information, visit Sexual health

Data source: National annual STI rates were calculated using the number of chlamydia, gonorrhea and infectious syphilis cases from the Canadian Notifiable Disease Surveillance System as numerators and Statistics Canada April 2022 yearly population estimates as denominators.

Observed differences in the data published here and the data published in provincial and territorial surveillance products (such as variation in reporting of first-time diagnoses) may be due to reporting delays, differences in the date data were extracted from the provincial and territorial surveillance databases or other reporting variations. Where such differences are noted, it is recommended that data and results from provincial and territorial products be used.

References

Footnote 1

Infectious syphilis includes the primary, secondary and early latent (less than one year after infection) stages of infection

Return to footnote 1 referrer

Footnote 2

Survey of the impact of COVID-19 on the ability to provide STBBI prevention, testing and treatment including harm reduction services in Canada. Public Health Agency of Canada, Centre for Communicable Diseases and Infection Control. 2021. Retrieved December 2022, from https://www.canada.ca/en/public-health/services/publications/diseases-conditions/survey-impact-covid-19-delivery-stbbi-prevention-testing-treatment.html

Return to footnote 2 referrer

Footnote 3

Thorington R, Sawatzky P, Lefebvre B, Diggle M, Hoang L, Patel S, Van Caessele P, Minion J, Garceau R, Matheson M, Haldane D, Gravel G, Mulvey MR, Martin I. Antimicrobial susceptibilities of Neisseria gonorrhoeae in Canada, 2020. Can Commun Dis Rep 2022;48(11/12):571–9. https://doi.org/10.14745/ccdr.v48i1112a10

Return to footnote 3 referrer

Footnote 4

Public Health Agency of Canada. Infectious syphilis and congenital syphilis in Canada, 2021. Can Commun Dis Rep 2022;48(11/12): 587. Retrieved February 2023, from https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2022-48/issue-11-12-november-december-2022/infectious-congenital-syphilis-canada-2021.html

Return to footnote 4 referrer

Page details

Date modified: